Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
04/19/2001 | WO2001002366A3 Substituted isoquinoline derivatives and their use as inticonvulsants |
04/19/2001 | WO2000045894A3 Use of pyrazole carboxamides |
04/19/2001 | WO1999032448A8 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
04/19/2001 | CA2388813A1 Heterocyclic sodium/proton exchange inhibitors and method |
04/19/2001 | CA2388505A1 5-membered heterocycle derivatives, their preparation and application as medicine |
04/19/2001 | CA2387493A1 Amino lactam sulfonamides as inhibitors of a.beta. protein production |
04/19/2001 | CA2386299A1 Antiprotozoal histone acetyl transferase inhibitors |
04/19/2001 | CA2384544A1 Amino lactam sulfonamides as inhibitors of a.beta. protein production |
04/18/2001 | EP1092716A2 Derivatives of benzothiophenes, benzofurans and indoles, method for their preparation and pharmaceutical compositions containing them |
04/18/2001 | EP1091957A1 Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria |
04/18/2001 | EP1091956A1 Muscarinic antagonists |
04/18/2001 | EP1091955A1 Quinolones as serine protease inhibitors |
04/18/2001 | EP1091953A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
04/18/2001 | EP1091952A1 Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer |
04/18/2001 | EP1091943A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
04/18/2001 | EP1091941A1 Novel benzimidazoles as corticotropin release factor antagonists |
04/18/2001 | EP1091937A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
04/18/2001 | EP1091741A1 Azepine derivatives having effects on serotonin related systems |
04/18/2001 | EP0968250B1 Soluble chromophores having improved solubilising groups |
04/18/2001 | EP0765321B1 2-amino-3-aroyl-benzo beta thiophenes and method of making the same |
04/18/2001 | EP0682663B1 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl b]pyran-2-ones useful to treat retroviral infections |
04/18/2001 | CN1291984A Glycine transport inhibitors |
04/18/2001 | CN1291892A Substituted oxoazaheterocyclyl factor Xa inhibitors |
04/18/2001 | CN1064679C Herbicidal thiocarbamoyltetrazolinones |
04/17/2001 | US6218538 Antagonists of n-type neuronal calcium channels useful in the treatment of cerebrovascular ischaemia and pain. |
04/17/2001 | US6218537 Process for making pyridyl and pyrimidine substituted imidazole compounds |
04/17/2001 | US6218431 Substituted biphenyls |
04/17/2001 | US6218427 Chromene-3-carboxylate derivatives |
04/17/2001 | US6218426 For therapy of mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated |
04/17/2001 | US6218423 Administering pyrrolidine derivative for therapy of nerve-related vision disorder, improving vision, treating memory impairment, or enhancing memory performance in animal |
04/17/2001 | US6218418 Therapy of cell proliferative disorders associated with an altered cell dependent kinase activity by administering amino pyrazole derivative to mammal |
04/17/2001 | US6218408 Selective NPY (Y5) antagonists (bicyclics) |
04/17/2001 | US6218406 As antitumor and antileukemic agents |
04/17/2001 | US6218394 4-Aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophene-methyl) piperazines |
04/17/2001 | US6218393 Anthranilic acid derivatives as multi drug resistance modulators |
04/17/2001 | US6218375 Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-β-cyclodextrin or 2-hydroxypropyl-β-cyclodextrin and method |
04/12/2001 | WO2001025229A1 Amide compounds |
04/12/2001 | WO2001025227A2 Quinolyl propyl piperidine derivatives and their use as antibacterial agents |
04/12/2001 | WO2001025220A1 Triazine kinase inhibitors |
04/12/2001 | WO2001025210A2 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands |
04/12/2001 | WO2001025209A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
04/12/2001 | WO2001025208A1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
04/12/2001 | WO2001025200A1 Cyclic amine compounds as ccr5 antagonists |
04/12/2001 | WO2001024828A2 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
04/12/2001 | WO2001024827A2 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
04/12/2001 | WO2001024796A1 1,2,4-triazole derivatives, composition, process of making and methods of use |
04/12/2001 | WO2000071533A3 1,4-dithiin and 1,4-dithiepin- 1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor |
04/12/2001 | WO1999057117A3 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
04/12/2001 | DE19948269A1 New compounds as integrin antagonists useful for treating e.g. cardiovascular disorders, rheumatoid arthritis, kidney failure, stroke, cancer, osteoporosis, psoriasis or infection |
04/12/2001 | CA2608807A1 Cyclic amine compounds as ccr5 antagonists |
04/12/2001 | CA2386457A1 Inhibitors of the endothelin signalling pathway and .alpha.v.beta.3 integrin receptor antagonists for combination therapy |
04/12/2001 | CA2386218A1 Triazine kinase inhibitors |
04/12/2001 | CA2386157A1 Amide compounds |
04/12/2001 | CA2386147A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
04/12/2001 | CA2383836A1 Quinolyl propyl piperidine derivatives and their use as antibacterial agents |
04/12/2001 | CA2351075A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
04/11/2001 | EP1090912A1 Amino acid derivatives and drugs containing the same as the active ingredient |
04/11/2001 | EP1089998A2 Epothilone derivatives and their synthesis and use |
04/11/2001 | EP1089993A1 5-ht 1f? agonists |
04/11/2001 | EP1089981A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis. |
04/11/2001 | EP1089980A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
04/11/2001 | EP1089977A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
04/11/2001 | EP1089973A1 Amidino and guanidino azetidinone tryptase inhibitors |
04/11/2001 | EP1089964A1 Hydrazine derivatives |
04/11/2001 | EP1089735A1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists |
04/11/2001 | EP0984963B1 Novel compounds |
04/11/2001 | EP0775113B1 N-substituted azabicycloheptane derivatives useful as neuroleptics |
04/11/2001 | CN1291190A 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonist |
04/11/2001 | CN1291183A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
04/11/2001 | CN1290702A Synthetic intermediate of cephalo olefine compound |
04/11/2001 | CN1290698A Quinoline-4-base deviative I |
04/11/2001 | CN1064356C New piperazine, piperidine and 1,2,5,6-tetrahydropyridine compounds process for preparation thereof, and pharmaceutical composition containing them |
04/11/2001 | CN1064354C Trilcyclic benzazepine vasopressin antagnonists |
04/11/2001 | CN1064350C Aryl and heteroaryl alkoxynaphtalene derivatives |
04/10/2001 | US6215016 Hematopoietic agents; preventing cytopenia |
04/10/2001 | US6214994 Treatment of neoplastic diseases, bacterial or fungal infections, and preventing or decreasing production of phosphorylated paired helical filament (phf) epitopes associated with alzheimer's disease |
04/10/2001 | US6214870 Antiarthritic agents; anticancer agents |
04/10/2001 | US6214845 Insecticidal N-(substituted arylmethyl)-4[bis(substituted phenyl or pyridyl)methyl] piperidines |
04/10/2001 | US6214829 Piperazine compounds, their preparation, and methods of using them |
04/10/2001 | US6214822 Substituted aza and diazacycloheptane and cyclooctane compounds and their use |
04/10/2001 | US6214818 Cephem compounds and pharmaceutical compositions containing the same |
04/05/2001 | WO2001023382A1 Pharmaceutically active sulfonyl hydrazide derivatives |
04/05/2001 | WO2001023381A1 Piperidine derivatives as reuptake inhibitors |
04/05/2001 | WO2001023380A1 Piperidine derivatives as serotonine reuptake inhibitors |
04/05/2001 | WO2001023379A1 Pharmaceutically active sulfonyl amino acid derivatives |
04/05/2001 | WO2001023378A1 Pharmaceutically active sulfonamide derivatives |
04/05/2001 | WO2001023376A1 Isonipecotamides for the treatment of integrin-mediated disorders |
04/05/2001 | WO2001023364A1 Quinazolinones |
04/05/2001 | WO2001023360A1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
04/05/2001 | WO2001022966A1 Caspases and apoptosis |
04/05/2001 | WO2000073284A3 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors |
04/05/2001 | WO2000068198A3 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
04/05/2001 | CA2386092A1 Piperidine derivatives |
04/05/2001 | CA2386085A1 Piperidine derivatives |
04/05/2001 | CA2385918A1 Quinazolinones |
04/05/2001 | CA2385001A1 Pharmaceutically active sulfonyl hydrazide derivatives |
04/05/2001 | CA2384997A1 Pharmaceutically active sulfonyl amino acid derivatives |
04/05/2001 | CA2352957A1 Isonipecotamides for the treatment of integrin-mediated disorders |
04/04/2001 | EP1088822A1 Pharmaceutically active sulfonyl hydrazide derivatives |
04/04/2001 | EP1088821A1 Pharmaceutically active sulfonamide derivatives |